Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026)
Alcon (ALC) recorded quarterly Net Income towards Common Stockholders of $189.0 million in Q1 2026, down 12.9% quarter-over-quarter from $217.0 million in Q4 2025.
Alcon (ALC) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Alcon's Net Income towards Common Stockholders history runs 11 years deep, the most recent figure standing at $189.0 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders changed N/A year-over-year to $189.0 million; the TTM figure through Mar 2026 stood at $819.0 million (up 6.36% YoY), while the FY2025 annual figure was $980.0 million, down 3.73% from the prior year.
- Net Income towards Common Stockholders was $189.0 million for Q1 2026 at Alcon, down from $217.0 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $284.0 million in Q4 2024 to a low of -$31.0 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged $195.8 million across 5 years, with a median of $213.0 million in 2023.
- Biggest YoY gain for Net Income towards Common Stockholders was 739.13% in 2022; the steepest drop was 121.99% in 2022.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$31.0 million in 2022, then jumped by 641.94% to $168.0 million in 2023, then soared by 69.05% to $284.0 million in 2024, then retreated by 23.59% to $217.0 million in 2025, then slipped by 12.9% to $189.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $189.0 million (Q1 2026), $217.0 million (Q4 2025), and $237.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Alcon | 25,681.50 | -1.66 Bn | 1.53 Bn | 189.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 189.00 Mn |
| Dec 31, 2025 | 217.00 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Jun 30, 2025 | 176.00 Mn |
| Dec 31, 2024 | 284.00 Mn |
| Sep 30, 2024 | 263.00 Mn |
| Jun 30, 2024 | 223.00 Mn |
| Mar 31, 2024 | 248.00 Mn |
| Dec 31, 2023 | 168.00 Mn |
| Sep 30, 2023 | 238.00 Mn |
| Jun 30, 2023 | 213.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | -31.00 Mn |
| Sep 30, 2022 | 147.00 Mn |
| Jun 30, 2022 | 147.00 Mn |
| Mar 31, 2022 | 200.00 Mn |
| Dec 31, 2021 | 141.00 Mn |
| Sep 30, 2021 | -23.00 Mn |
| Jun 30, 2021 | 191.00 Mn |
| Mar 31, 2021 | 109.00 Mn |